EP3252069

(11.beta.,17.beta.)-17-hýdroxý-11-[4-(metýlsúlfónýl)fenýl]-17-(pentalflúrmetýl)estra-4,9-díen-3-ón til að nota við að meðhöndla af sjúkdóma

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    7.7.2010
  • EP published:
    3.4.2019
  • EP application number:
    17176264.4
  • Max expiry date:
    6.7.2030
  • Expiry date:
    6.7.2023
  • Title:
    (11.BETA.,17.BETA.)-17-HYDROXY-11-[4-(METHYLSULFONYL)PHENYL]-17-(PENTALFUOROMETHYL)ESTRA-4,9-DIEN-3-ONE FOR USE IN THE TREATMENT OF DISEASES

Timeline

Today
7.7.2010EP application
3.4.2019EP Publication
12.6.2019Translation submitted
15.7.2019Registration published
6.7.2023Expires

Owner

  • Name:
    Bayer Pharma Aktiengesellschaft
  • Address:
    Müllerstrasse 178, 13353, Berlin, DE

Inventor

  • Name:
    Schwede, Wolfgang
  • Address:
    Glienicke, DE
  • Name:
    Klar, Ulrich
  • Address:
    Berlin, DE
  • Name:
    Möller, Carsten
  • Address:
    Berlin, DE
  • Name:
    Rotgeri, Andrea
  • Address:
    Berlin, DE
  • Name:
    Bone, Wilhelm
  • Address:
    Berlin, DE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    102009034362
  • Date:
    20.7.2009
  • Country:
    DE

Classification

  • Categories:
    C07J 31/00, C07J 41/00, A61K 31/567, A61P 5/36, A61K 31/573

Annual fees

Number

Paid

Expires

Payer

Number: 10

Paid: 25.6.2019

Expires: 6.7.2020

Payer: Árnason Faktor

Number: 11

Paid: 25.6.2020

Expires: 6.7.2021

Payer: Árnason Faktor ehf.

Number: 12

Paid: 24.6.2021

Expires: 6.7.2022

Payer: Árnason Faktor ehf.

Number: 13

Paid: 29.6.2022

Expires: 6.7.2023

Payer: Árnason Faktor ehf.

Upload documents